Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Location: Switzerland, Zurich, Horgen
Employees: 1-10
Total raised: $7.83M
Founded date: 2022
Investors 1
| Date | Name | Website |
| 25.03.2024 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.11.2022 | Seed | $7.83M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 19.02.2024 | Companies worldwide embrace digitalisation with Swiss startu... | Decentriq, a leading provider of data clean room solutions, has entered into a commercial agreement... | startuptic... |
| 19.04.2023 | Ten biotech startups head to Boston | startuptic... | |
| 11.11.2022 | Navignostics raises CHF 7.5M to advance precision cancer med... | startuptic... | |
| 02.09.2022 | UZH Life Science Fund invests in Navignostics | startuptic... | |
| - | Navignostics AG | “Navignostics' mission is to identify the ideal treatment to battle each cancer patient’s disease us... | fastfounde... |